- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03313388
Tart Cherry Juice for Exercise Performance and Recovery
The Effect of Tart Cherry Juice on Fat Metabolism, Exercise Performance, and Recovery
Panoramica dello studio
Descrizione dettagliata
Tart cherries are rich in bioactive components (i.e. flavonoids) that have anti-inflammatory and anti-oxidant properties. Inflammation and lipid peroxidation causes damage of skeletal muscle membranes during intense exercise. The damage of muscle increases the amount of time for muscle to recover from intense exercise, and can cause muscle strength to be reduced for days. When tart cherries in a concentrated form (i.e. as juice or powder) are consumed in the days leading up to intense exercise, there is a protective effect against inflammation, and lipid peroxidation . This theoretically prevents damage to the lipid component of muscle fibre membranes and helps to preserve muscle function - when muscle is damaged by intense exercise (i.e. either repetitive aerobic activity or high-force muscle contraction), consumption of cherry juice enhances the rate of muscle strength recovery following exercise compared to when a placebo (i.e. non-cherry) beverage is consumed . Muscle damage may be protected by cherry juice consumption; however, all studies evaluating the protective effect of cherries have assessed muscle damage by measuring muscle proteins in the blood. This rather indirect measure of muscle damage is highly variable and not always an accurate assessment of muscle damage; this may be why some studies indicate a reduction in markers of muscle damage with cherry juice consumption while others do not.
A more direct assessment of muscle damage can be obtained by applying electrical stimulation at different frequencies to a muscle before and after intense exercise and assessing the reduction in force output in response to low-frequency and high-frequency stimulation. After intense exercise, the force output at low frequencies of stimulation is often reduced, while the force output at high frequencies is maintained; a phenomenon termed "low frequency fatigue". When muscle is stimulated to contract (either voluntarily by the nervous system or involuntarily through electrical stimulation) calcium is released inside muscle. This calcium release leads to muscle contraction. When muscle undergoes intense exercise, there is damage to muscle membranes, including membranes inside muscle that are responsible for calcium release. This causes a lower amount of calcium to be released with each muscle contraction. Normally, if high frequencies of electrical stimulation are applied to muscle, a very large amount of calcium is released inside muscle - an amount which is "more than enough" to cause a high amount of muscle contraction and high force output. If muscle fibre membranes responsible for release of calcium are damaged, a lower amount of calcium is released, but because "more than enough" calcium is usually released with high frequency stimulation, the lower amount of calcium released with muscle damage is still enough to cause high force of muscle contraction. The force response to low frequencies of stimulation; however, is dramatically reduced when muscle is damaged - usually only a small amount of calcium is released when low frequencies of stimulation are delivered to muscle. Following muscle damage, the smaller amount of calcium released causes lower force production at low stimulation frequency. Low force production at low stimulation frequencies, with a relatively maintained force production at high stimulation frequencies therefore indicates that muscle damage has occurred. This lower muscle force capability at low frequencies of stimulation has dramatic effects on endurance performance because typical endurance performance relies on repeated low-force muscle contractions, as opposed to the few high-force contractions that might be required in other sports (i.e. short sprinting events or field events such as shot put).
The study we are proposing will use this measurement (i.e. ratio of low frequency force to high frequency force output) as a more direct measure of muscle damage. We predict that if cherry juice is consumed in the days leading up to a bout of muscle-damaging endurance exercise, muscle damage will be lower (as indicated by a faster recovery of low-frequency fatigue following the bout of exercise) than when a comparison-drink (i.e. Gatorade) is consumed.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada, S7N 5B2
- College of Kinesiology, University of Saskatchewan
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- experienced cyclist (i.e. bicycle exercise at a vigorous intensity on a regular basis)
Exclusion Criteria:
- Allergies to cherries
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione incrociata
- Mascheramento: Triplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Tart Cherry Juice
290 mL per day of Tart Cherry juice for 7 days
|
Beverage to be consumed
|
|
Comparatore attivo: Gatorade
290 mL per day of Gatorade for 7 days
|
Beverage to be consumed
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Time time performance
Lasso di tempo: Day 5 of beverage consumption
|
Time to complete 10 km of cycling
|
Day 5 of beverage consumption
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Fat oxidation
Lasso di tempo: Day 5 of beverage consumption
|
Fat oxidation determined from gas analysis
|
Day 5 of beverage consumption
|
|
Carbohydrate oxidation
Lasso di tempo: Day 5 of beverage consumption
|
Carbohydrate oxidation determined from gas analysis
|
Day 5 of beverage consumption
|
|
Blood pressure
Lasso di tempo: Day 5 of beverage consumption
|
Blood pressure assessed by continuous blood pressure monitor
|
Day 5 of beverage consumption
|
|
Muscle pain
Lasso di tempo: Change from baseline to before, and immediately, 24 hours, and 48 hours after exercise
|
Muscle pain determined by a visual analog scale (participant marks a scale from 0 to 100 mm.
A score of 0 mm is "no pain".
A score of 100 mm is maximal pain).
|
Change from baseline to before, and immediately, 24 hours, and 48 hours after exercise
|
|
Quadriceps strength
Lasso di tempo: Change from baseline to before, and immediately, 24 hours, and 48 hours after exercise
|
Knee extensor strength determined by isometric contraction
|
Change from baseline to before, and immediately, 24 hours, and 48 hours after exercise
|
|
Low frequency fatigue
Lasso di tempo: Change from baseline to before, immediately, 24 hours, and 48 hours after exercise
|
Measured by force production at low and high stimulation frequencies as an index of muscle damage
|
Change from baseline to before, immediately, 24 hours, and 48 hours after exercise
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- 16-273
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Drink
-
TCI Co., Ltd.Completato
-
TCI Co., Ltd.Completato
-
Fresenius Kabi Taiwan Ltd.CompletatoCancro | Malnutrizione (calorie)Taiwan
-
Fresenius Kabi Taiwan Ltd.Chung Shan Medical UniversityCompletato
-
Medical College of WisconsinNon ancora reclutamentoDiabete di tipo 1 | Diabete mellito di tipo 1 | diabete di tipo 1 | Dolcificante Non NutritivoStati Uniti
-
Fresenius KabiCompletatoNutrizione enteraleGermania
-
Simply Plus Co., Ltd.Chia Nan University of Pharmacy & ScienceAttivo, non reclutanteInvecchiamento della pelleTaiwan
-
University of FloridaCompletato
-
University of CologneFresenius KabiCompletatoInsufficienza renale acutaGermania
-
National University of SingaporeBezos Earth FundAttivo, non reclutanteInvecchiamento | Metabolismo proteicoSingapore